Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
The SURPASS and SURMOUNT trialswhich led to FDA approval of tirzepatidedocumented systolic blood pressure reductions of 46 mmHg on average, with some patients seeing 10+ mmHg drops
Documented cases of pancreatitis with Mounjaro While clinical trials show low risk, there have been documented cases of pancreatitis with Mounjaro that warrant awareness
Key Research Attributes Highly innovative triple-agonist activity: GLP-1, GIP, and glucagon receptors
Compounded GLP-1 medications have not undergone the same clinical trial review process as FDA-approved medications
Ongoing Clinical Trials in Pediatric Obesity Several studies are underway to investigate tirzepatide's role in managing adolescent obesity and prediabetes, with results expected to guide future regulatory approval
Collagen peptides are everywhere right now
